WASHINGTON, DC—Updated data from the SMART trial show that supra-annular self-expanding valves yield similar clinical outcomes as balloon-expandable valves at 2 years, but with less risk of ...
In patients with aortic stenosis and a small aortic annulus, results showed comparable composite outcome of mortality, disabling stroke, and heart failure hospitalization, and continued superior valve ...
Medtronic : Data Confirms Superior Valve Performance Of Evolut TAVR System In Small Annulus Patients
Additional results demonstrated that Evolut TAVR showed the following relative to SAPIEN TAVR: five times less prosthetic valve thrombosis and nine times less hemodynamic structural valve dysfunction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback